NurExone Biologic Secures Master Cell Bank NurExone Biologic Secures Master Cell Bank - a Key Milestone for Therapeutic Exosome Production

NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process NurExone’s reliable production from diverse biological sources allows NurExone to optimize exosome production with consistency and efficiency

NurExone’s Intellectual Property Portfolio Expands NurExone's Intellectual Property portfolio is expanding to encompass processes and compositions related to exosomes in large-scale production